HopeStage
Study directory

Depression studies

Depression involves persistent low mood or loss of interest, often with tiredness and changes in sleep or appetite.

Back to overview
More filters: keywords, city, remote
7264studies shown
Showing 25-36 of 7,264
Device study icon
RecruitingNCT05773755

DBS for TRD With the Medtronic Percept PC

Official study title

Deep Brain Stimulation for Treatment Resistant Depression: Exploration of Local Field Potentials (LFPs) With the Medtronic Percept PC System

In New York
DepressionDevice studyAges 25–70
Countries
United States
Sponsor
Helen Mayberg, MD
Behavioral study icon
RecruitingNCT06404320

Physical Activity Program for TRD

Official study title

Remotely Delivered Physical Activity Program for Treatment-Resistant Depression: A Pilot Randomized Controlled Trial

In Toronto
DepressionBehavioural studyAges 18–65
Countries
Canada
Sponsor
Unity Health Toronto
Drug study icon
RecruitingACTRN12620001095954

The Candesartan Adjunctive Major Depression study - CADET: A study

Official study title

The Candesartan Adjunctive Major Depression Trial - CADET: A double-blind, randomised, placebo-controlled trial to evaluate the effect of candesartan on mood in participants with major depressive disorder

Multiple locations, including Geelong
DepressionInterventional studyAges 18+
Countries
Australia
Sponsor
Deakin University
Drug study icon
RecruitingNCT07680140

Biomarker-Guided Antidepressant Selection

Official study title

Biomarker-Guided Antidepressant Selection for Treatment-Resistant Depression

In New York
DepressionMedication studyAges 18–70
Countries
United States
Sponsor
Weill Medical College of Cornell University
Drug study icon
RecruitingNCT07569198

Ketamine With Dialectical Behavioural Therapy (DBT) for Suicide prevention in Individuals With Treatment-Resistant Depression and Borderline Personality Disorder (KET-DBT)

Official study title

Combining Ketamine With Dialectical Behavioural Therapy (DBT) for Suicidality in Individuals With Treatment-Resistant Depression and Borderline Personality Disorder: A Phase II Randomized, Midazolam-Controlled Clinical Trial (KET-DBT)

In Toronto
Depression, Personality disorders, ...Medication studyAges 18–70
Countries
Canada
Sponsor
Joshua Rosenblat
Drug study icon
RecruitingNCT07610473

Effectiveness of DT-101 in depression

What is this study about?

This study evaluates the safety and effectiveness of DT-101 for people with depression.

Multiple locations, including Phoenix
DepressionMedication studyAges 18–75
Countries
United States
Sponsor
Draig Therapeutics Ltd
Other study type icon
RecruitingNCT07533773

Investigating Functional Changes in the Frontotemporal Cortex of people with Major Depressive Disorder Following Electroconvulsive Therapy or Magnetic Seizure Therapy Using Functional Near-infrared Spectroscopy (fNIRS)

Official study title

Investigating Functional Changes in the Frontotemporal Cortex of Patients With Major Depressive Disorder Following Electroconvulsive Therapy or Magnetic Seizure Therapy Using Functional Near-infrared Spectroscopy

In Hefei
DepressionInterventional studyAges 12–65
Countries
China
Sponsor
The Second Hospital of Anhui Medical University
Data coverage

Public registry coverage is progressing

HopeStage gathers information about mental health clinical trials from the public registries we currently index. We are progressively improving registry coverage, but this does not mean that every study in the world is already included.